Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
Abstract Background This research reviewed major Clinical Trial Registries (CTRs) and assessed the availability of fields on quality assurance for approved medicines used as Investigational Medicinal Products (IMPs) in phase IV clinical trials. Methods Two reviewers independently assessed CTRs of th...
Main Authors: | Yorokpa Joachim Doua, Hanneke Dominicus, Julius Mugwagwa, Suzelle Magalie Gombe, Jude Nwokike |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3277-8 |
Similar Items
-
Clinical trials in dentistry in India: Analysis from trial registry
by: S Gowri, et al.
Published: (2017-01-01) -
A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials
by: Sowparnika Treasa Sabu, et al.
Published: (2024-01-01) -
The Egyptian clinical trials’ registry profile: Analysis of three trial registries (International Clinical Trials Registry Platform, Pan-African Clinical Trials Registry and clinicaltrials.gov)
by: Ahmed A. Zeeneldin, et al.
Published: (2016-01-01) -
Open-access clinical trial registries: the Italian scenario
by: Mosconi Paola, et al.
Published: (2012-10-01) -
Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
by: Brandon Michael Henry, et al.
Published: (2023-06-01)